Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
KYNB
$5.49
+3.98%
KYNB
· Kyntra Bio, Inc.
Market Cap
$21.38M
Shares
4.05M
Volume · Oct 20
13.55K
Avg daily vol (3M)
19.56K
All webcasts
Earnings call · FY2023 Q2
Kyntra Bio, Inc. (KYNB) Q2 2023 Earnings Call
Revenue
$44.32M
+48.7% YoY
Diluted EPS
-$22.50
Net income
-$87.68M
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 7, 2023.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Expected reduction of total annualized U.S. GAAP expenses
annualized
|
$100M – $120M | GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2023 · complete as-filed document